REGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.48%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $71,913,487.25

Regeneron Pharmaceuticals Insider Trading History Chart

Regeneron Pharmaceuticals Share Price & Price History

^$599.21

▲ +11.36 (1.93%)

As of 04/24/2025 04:58 PM ET

Days: 30 | 90 | 365

Regeneron Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/28/2024	Christopher R. Fenimore	CFO	Sell	5,680	$1,205.33	$6,846,274.40	15,305
8/7/2024	Jason Pitofsky	VP	Sell	487	$1,070.00	$521,090.00	4,204
7/11/2024	Joseph J. Larosa	EVP	Sell	1,866	$1,088.95	$2,031,980.70	37,937
7/1/2024	Arthur F. Ryan	Director	Sell	100	$1,059.24	$105,924.00	17,882
7/1/2024	Marion Mccourt	EVP	Sell	1,137	$1,047.11	$1,190,564.07	12,931
6/24/2024	Bonnie L. Bassler	Director	Sell	756	$1,062.00	$802,872.00	1,382
6/14/2024	Michael S. Brown	Director	Sell	1,535	$1,040.00	$1,596,400.00	1,382
6/11/2024	Leonard S. Schleifer	CEO	Sell	9,064	$1,015.43	$9,203,857.52	55,134
6/6/2024	Leonard S. Schleifer	CEO	Sell	787	$1,015.02	$798,820.74	64,198
6/5/2024	Bonnie L. Bassler	Director	Sell	827	$1,011.00	$836,097.00	1,382
5/28/2024	Michael S. Brown	Director	Sell	1,172	$974.86	$1,142,535.92	1,382
5/17/2024	Leonard S. Schleifer	CEO	Sell	22,830	$979.23	$22,355,820.90	466,877
5/14/2024	Leonard S. Schleifer	CEO	Sell	25,000	$979.25	$24,481,250.00	408,200
3/14/2024	Andrew J. Murphy	EVP	Sell	5,783	$956.47	$5,531,266.01	48,306
3/1/2024	Arthur F. Ryan	Director	Sell	100	$982.05	$98,205.00	18,282
3/1/2024	Marion Mccourt	EVP	Sell	358	$967.50	$346,365.00	13,431
2/26/2024	Bonnie L. Bassler	Director	Sell	854	$979.25	$836,279.50	1,382
2/22/2024	Joseph J. Larosa	EVP	Sell	1,000	$967.65	$967,650.00	37,543
2/7/2024	Joseph J. Larosa	EVP	Sell	1,000	$950.00	$950,000.00	38,543
2/5/2024	Marion Mccourt	EVP	Sell	1,000	$934.71	$934,710.00	13,789
2/1/2024	Arthur F. Ryan	Director	Sell	100	$954.22	$95,422.00	18,382
1/30/2024	Bonnie L. Bassler	Director	Sell	827	$959.00	$793,093.00	1,382
1/23/2024	Joseph L. Goldstein	Director	Sell	2,707	$950.00	$2,571,650.00	6,382
1/2/2024	George D. Yancopoulos	Insider	Sell	16,848	$900.00	$15,163,200.00	180,000
12/27/2023	Christopher R. Fenimore	SVP	Sell	2,448	$856.71	$2,097,226.08	14,372
12/27/2023	Michael S. Brown	Director	Sell	2,049	$898.00	$1,840,002.00	1,247
12/21/2023	Christopher R. Fenimore	SVP	Sell	1,680	$844.01	$1,417,936.80	17,070
12/1/2023	Arthur F. Ryan	Director	Sell	100	$817.30	$81,730.00	18,447
11/7/2023	Arthur F. Ryan	Director	Sell	100	$827.90	$82,790.00	18,547
11/1/2023	Marion Mccourt	EVP	Sell	1,000	$783.91	$783,910.00	19,803
10/13/2023	Huda Y. Zoghbi	Director	Sell	1,000	$850.00	$850,000.00	1,247
10/2/2023	Marion Mccourt	EVP	Sell	1,038	$827.00	$858,426.00	19,803
8/24/2023	Plew Daniel P Van	EVP	Sell	6,197	$841.71	$5,216,076.87	21,508
8/23/2023	Christine A. Poon	Director	Sell	12,280	$839.97	$10,314,831.60	2,037
8/23/2023	Robert E. Landry	CFO	Sell	223	$844.00	$188,212.00	31,699
8/22/2023	Neil Stahl	EVP	Sell	11,665	$840.98	$9,810,031.70	53,100
8/21/2023	Bonnie L. Bassler	Director	Sell	853	$829.00	$707,137.00	1,247
8/10/2023	Bonnie L. Bassler	Director	Sell	853	$789.00	$673,017.00	1,247
8/1/2023	Arthur F. Ryan	Director	Sell	100	$736.59	$73,659.00	18,647
7/3/2023	Arthur F. Ryan	Director	Sell	100	$716.88	$71,688.00	18,747
7/3/2023	Marion Mccourt	EVP	Sell	250	$710.09	$177,522.50	20,303
6/1/2023	Arthur F. Ryan	Director	Sell	100	$735.42	$73,542.00	18,847
6/1/2023	Marion Mccourt	EVP	Sell	250	$736.00	$184,000.00	20,553
4/21/2023	Michael S. Brown	Director	Sell	3,070	$798.42	$2,451,149.40	1,247
4/3/2023	Arthur F. Ryan	Director	Sell	100	$819.31	$81,931.00	19,047
4/3/2023	Marion Mccourt	EVP	Sell	1,100	$818.80	$900,680.00	20,803
3/27/2023	Robert E. Landry	CFO	Sell	183	$821.70	$150,371.10	32,929
3/24/2023	Bonnie L. Bassler	Director	Sell	1,240	$818.00	$1,014,320.00	1,247
3/23/2023	Christopher R. Fenimore	SVP	Sell	2,192	$806.47	$1,767,782.24	18,409
3/23/2023	George D. Yancopoulos	Insider	Sell	3,656	$804.26	$2,940,374.56	196,848
3/1/2023	Arthur F. Ryan	Director	Sell	100	$762.50	$76,250.00	19,147
3/1/2023	Marion Mccourt	EVP	Sell	1,100	$759.89	$835,879.00	20,803
2/7/2023	Marion Mccourt	EVP	Sell	1,000	$769.04	$769,040.00	22,079
2/6/2023	George D. Yancopoulos	Insider	Sell	13,189	$800.08	$10,552,255.12	200,504
2/6/2023	Joseph L. Goldstein	Director	Sell	3,613	$800.00	$2,890,400.00	6,247
2/6/2023	Robert E. Landry	CFO	Sell	752	$788.88	$593,237.76	32,105
2/3/2023	Bonnie L. Bassler	Director	Sell	1,021	$779.00	$795,359.00	1,247
2/3/2023	Robert E. Landry	CFO	Sell	739	$764.50	$564,965.50	32,105
1/27/2023	Michael S. Brown	Director	Sell	1	$747.00	$747.00	1,247
12/28/2022	N. Anthony Coles	Director	Sell	5,758	$714.11	$4,111,845.38	1,093
12/12/2022	Marion Mccourt	EVP	Sell	264	$730.17	$192,764.88	19,106
12/8/2022	Bonnie L. Bassler	Director	Sell	218	$779.00	$169,822.00	1,082
11/23/2022	Plew Daniel P Van	EVP	Sell	11,972	$740.75	$8,868,259.00	30,578
11/4/2022	Marion Mccourt	EVP	Sell	1,000	$727.82	$727,820.00	19,644
10/17/2022	Robert E. Landry	CFO	Sell	358	$739.50	$264,741.00	28,744
10/5/2022	Christopher R. Fenimore	SVP	Sell	1,844	$749.00	$1,381,156.00	16,425
10/3/2022	Christopher R. Fenimore	SVP	Sell	3,346	$724.00	$2,422,504.00	18,269
10/3/2022	Marc Tessier-Lavigne	Director	Sell	3,612	$718.00	$2,593,416.00	2,269
10/3/2022	Marion Mccourt	EVP	Sell	1,100	$705.39	$775,929.00	19,644
9/30/2022	Marc Tessier-Lavigne	Director	Sell	3,428	$698.00	$2,392,744.00	2,269
9/12/2022	Plew Daniel P Van	EVP	Sell	4,696	$716.38	$3,364,120.48	30,578
9/9/2022	Bonnie L. Bassler	Director	Sell	609	$741.00	$451,269.00	1,082
8/9/2022	Christine A. Poon	Director	Sell	15,000	$620.91	$9,313,650.00	1,872
8/5/2022	Neil Stahl	EVP	Sell	23,782	$612.61	$14,569,091.02	52,795
8/4/2022	Arthur F. Ryan	Director	Sell	10,453	$621.29	$6,494,344.37	18,408
8/1/2022	Marion Mccourt	EVP	Sell	1,100	$581.53	$639,683.00	19,644
7/1/2022	Marion Mccourt	EVP	Sell	1,100	$587.76	$646,536.00	19,644
5/2/2022	Arthur F. Ryan	Director	Sell	100	$650.78	$65,078.00	22,182
5/2/2022	Marion Mccourt	EVP	Sell	1,100	$656.97	$722,667.00	19,644

SEC Filings (Institutional Ownership Changes) for Regeneron Pharmaceuticals (NASDAQ:REGN)

83.31% of Regeneron Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regeneron Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2025	Allspring Global Investments Holdings LLC	39,630	$24.45M	0.0%	-8.8%	0.036%
4/24/2025	3Chopt Investment Partners LLC	409	$0.26M	0.1%	N/A	0.000%
4/24/2025	Mirae Asset Global Investments Co. Ltd.	53,086	$33.28M	0.1%	-4.2%	0.049%
4/24/2025	Paragon Capital Management Inc.	2,210	$1.40M	1.1%	+25.3%	0.002%
4/24/2025	Hunter Perkins Capital Management LLC	8,482	$5.38M	1.2%	N/A	0.008%
4/24/2025	Illinois Municipal Retirement Fund	21,837	$13.85M	0.2%	+14.6%	0.020%
4/24/2025	Loring Wolcott & Coolidge Fiduciary Advisors LLP MA	96,473	$56.71M	0.5%	-9.1%	0.088%
4/24/2025	Diversified Trust Co	2,874	$1.82M	0.0%	+23.3%	0.003%
4/24/2025	TFC Financial Management Inc.	202	$0.13M	0.0%	-25.7%	0.000%
4/24/2025	PDS Planning Inc	421	$0.27M	0.0%	+24.6%	0.000%
4/23/2025	Creative Financial Designs Inc. ADV	220	$0.14M	0.0%	+9.5%	0.000%
4/23/2025	Sequoia Financial Advisors LLC	1,615	$1.02M	0.0%	-7.7%	0.001%
4/23/2025	Robeco Institutional Asset Management B.V.	112,495	$71.35M	0.1%	-13.0%	0.103%
4/23/2025	Golden State Wealth Management LLC	95	$60K	0.0%	+265.4%	0.000%
4/23/2025	Bessemer Group Inc.	1,218	$0.77M	0.0%	-76.0%	0.001%
4/23/2025	Spire Wealth Management	180	$0.11M	0.0%	+13.9%	0.000%
4/23/2025	Adams Diversified Equity Fund Inc.	19,700	$12.49M	0.5%	-9.2%	0.018%
4/23/2025	Golden State Equity Partners	1,446	$0.92M	0.2%	+6.5%	0.001%
4/23/2025	Global Assets Advisory LLC	759	$0.44M	0.1%	N/A	0.001%
4/23/2025	Strategic Investment Advisors MI	343	$0.22M	0.0%	-10.9%	0.000%
4/23/2025	Moran Wealth Management LLC	19,801	$12.56M	0.4%	+0.6%	0.018%
4/23/2025	Cornerstone Wealth Group LLC	8,270	$5.25M	0.4%	+114.0%	0.008%
4/23/2025	Sheets Smith Wealth Management	1,226	$0.78M	0.1%	+5.7%	0.001%
4/23/2025	Chevy Chase Trust Holdings LLC	221,210	$140.30M	0.4%	-3.7%	0.202%
4/23/2025	Sava Infond d.o.o.	800	$0.51M	0.1%	+15.9%	0.001%
4/23/2025	Ledyard National Bank	6,245	$3.96M	0.4%	-4.3%	0.006%
4/23/2025	Keudell Morrison Wealth Management	585	$0.37M	0.1%	+6.6%	0.001%
4/23/2025	E Fund Management Hong Kong Co. Ltd.	40	$25K	0.0%	+344.4%	0.000%
4/23/2025	Legacy Advisors LLC	435	$0.28M	0.0%	+20.2%	0.000%
4/23/2025	Asset Management One Co. Ltd.	62,338	$39.54M	0.1%	+3.9%	0.057%
4/23/2025	Oppenheimer Asset Management Inc.	1,965	$1.25M	0.0%	N/A	0.002%
4/23/2025	Oppenheimer & Co. Inc.	18,143	$11.51M	0.2%	+8.2%	0.017%
4/22/2025	XML Financial LLC	592	$0.38M	0.0%	-43.3%	0.001%
4/22/2025	Stiles Financial Services Inc	4,096	$2.60M	1.0%	+5.1%	0.004%
4/22/2025	Illumine Investment Management LLC	3,106	$1.97M	1.6%	+3.9%	0.003%
4/22/2025	Cambridge Investment Research Advisors Inc.	3,920	$2.49M	0.0%	-9.5%	0.004%
4/22/2025	Westhampton Capital LLC	1,085	$0.69M	0.4%	+2.1%	0.001%
4/22/2025	Kentucky Retirement Systems Insurance Trust Fund	3,040	$1.93M	0.1%	+9.3%	0.003%
4/22/2025	Kentucky Retirement Systems	7,137	$4.53M	0.1%	-2.1%	0.007%
4/22/2025	North Point Portfolio Managers Corp OH	17,234	$10.93M	1.9%	+1.2%	0.016%
4/22/2025	Intact Investment Management Inc.	780	$0.50M	0.0%	+56.0%	0.001%
4/22/2025	Nilsine Partners LLC	1,346	$0.85M	0.1%	+33.8%	0.001%
4/22/2025	Weaver Capital Management LLC	1,335	$0.85M	0.2%	-3.3%	0.001%
4/22/2025	Praxis Investment Management Inc.	3,501	$2.22M	0.2%	-8.6%	0.003%
4/22/2025	Marietta Wealth Management LLC	10,778	$6.84M	1.0%	+30.2%	0.010%
4/22/2025	Perfromance Wealth Partners LLC	407	$0.26M	0.0%	N/A	0.000%
4/22/2025	Putney Financial Group LLC	142	$90K	0.1%	-11.8%	0.000%
4/21/2025	Avior Wealth Management LLC	880	$0.56M	0.0%	-26.1%	0.001%
4/21/2025	River Street Advisors LLC	615	$0.39M	0.2%	+11.2%	0.001%
4/21/2025	Retirement Systems of Alabama	131,382	$83.33M	0.3%	+476.4%	0.120%
4/21/2025	Blue Trust Inc.	331	$0.21M	0.0%	+18.2%	0.000%
4/21/2025	Bay Colony Advisory Group Inc d b a Bay Colony Advisors	1,676	$1.07M	0.2%	+30.5%	0.002%
4/21/2025	United Advisor Group LLC	381	$0.24M	0.0%	-16.3%	0.000%
4/21/2025	Plimoth Trust Co. LLC	807	$0.51M	0.1%	-3.6%	0.001%
4/21/2025	Envestnet Portfolio Solutions Inc.	1,771	$1.12M	0.0%	-34.0%	0.002%
4/21/2025	Premier Path Wealth Partners LLC	344	$0.22M	0.0%	N/A	0.000%
4/21/2025	Aspiriant LLC	364	$0.23M	0.0%	-5.9%	0.000%
4/21/2025	State of Alaska Department of Revenue	17,325	$10.99M	0.1%	+1.9%	0.016%
4/21/2025	Prentiss Smith & Co. Inc.	2,110	$1.34M	0.9%	+3.7%	0.002%
4/21/2025	Kingswood Wealth Advisors LLC	1,084	$0.68M	0.0%	+1.8%	0.001%
4/18/2025	Clarius Group LLC	1,129	$0.72M	0.0%	+82.1%	0.001%
4/18/2025	CENTRAL TRUST Co	2,261	$1.43M	0.0%	-8.3%	0.002%
4/18/2025	PKO Investment Management Joint Stock Co	15,300	$9.70M	1.1%	+41.7%	0.014%
4/18/2025	Rakuten Securities Inc.	187	$0.12M	0.1%	+379.5%	0.000%
4/18/2025	Cardinal Capital Management	8,036	$5.10M	0.8%	+2.1%	0.007%
4/17/2025	Schaper Benz & Wise Investment Counsel Inc. WI	20,098	$12.75M	1.0%	+4.0%	0.018%
4/17/2025	Grove Bank & Trust	810	$0.51M	0.1%	+1,783.7%	0.001%
4/17/2025	QRG Capital Management Inc.	4,184	$2.65M	0.0%	-79.8%	0.004%
4/17/2025	Sagespring Wealth Partners LLC	828	$0.53M	0.0%	+54.5%	0.001%
4/17/2025	Shikiar Asset Management Inc.	550	$0.35M	0.1%	-28.6%	0.001%
4/17/2025	BDF Gestion	4,453	$2.82M	0.3%	-11.5%	0.004%
4/17/2025	Sowell Financial Services LLC	557	$0.35M	0.0%	N/A	0.001%
4/17/2025	Montecito Bank & Trust	1,274	$0.81M	0.1%	+1.8%	0.001%
4/17/2025	Janney Montgomery Scott LLC	28,042	$17.79M	0.1%	+21.6%	0.026%
4/17/2025	Mission Wealth Management LP	786	$0.50M	0.0%	+47.7%	0.001%
4/17/2025	Pflug Koory LLC	1,008	$0.64M	0.4%	-3.1%	0.001%
4/17/2025	Cyndeo Wealth Partners LLC	677	$0.43M	0.0%	-9.5%	0.001%
4/17/2025	Forefront Wealth Management Inc.	3,121	$1.98M	1.8%	+0.8%	0.003%
4/17/2025	CHB Investment Group LLC	2,597	$1.65M	0.9%	+3.3%	0.002%
4/17/2025	Warther Private Wealth LLC	464	$0.29M	0.1%	-90.1%	0.000%
4/17/2025	Traphagen Investment Advisors LLC	770	$0.49M	0.1%	+11.9%	0.001%
4/17/2025	Mn Services Vermogensbeheer B.V.	39,600	$25.12M	0.2%	-6.8%	0.036%
4/17/2025	Asio Capital LLC	3,995	$2.53M	0.5%	+13.6%	0.004%
4/17/2025	Brighton Jones LLC	1,003	$0.64M	0.0%	+5.8%	0.001%
4/17/2025	Exchange Traded Concepts LLC	3,352	$2.13M	0.0%	-45.6%	0.003%
4/17/2025	Factory Mutual Insurance Co.	12,100	$7.67M	0.1%	+210.3%	0.011%
4/17/2025	Ritholtz Wealth Management	486	$0.31M	0.0%	+7.8%	0.000%
4/17/2025	Dohj LLC	589	$0.37M	0.1%	+15.0%	0.001%
4/16/2025	Everpar Advisors LLC	446	$0.28M	0.2%	-7.1%	0.000%
4/16/2025	Opal Wealth Advisors LLC	244	$0.16M	0.0%	N/A	0.000%
4/16/2025	Wealth Enhancement Advisory Services LLC	33,745	$21.40M	0.0%	-28.0%	0.031%
4/16/2025	New England Research & Management Inc.	605	$0.38M	0.2%	N/A	0.001%
4/16/2025	Everhart Financial Group Inc.	512	$0.33M	0.0%	+45.5%	0.000%
4/16/2025	Marshall Financial Group LLC	1,249	$0.79M	0.2%	+28.8%	0.001%
4/16/2025	Smithbridge Asset Management Inc. DE	5,368	$3.41M	0.6%	N/A	0.005%
4/16/2025	Osprey Private Wealth LLC	3,530	$2.24M	1.3%	N/A	0.003%
4/16/2025	RMR Wealth Builders	2,141	$1.36M	0.1%	N/A	0.002%
4/16/2025	NorthCrest Asset Manangement LLC	11,903	$7.55M	0.2%	+4.9%	0.011%
4/16/2025	Rockland Trust Co.	402	$0.26M	0.0%	N/A	0.000%
4/16/2025	Bellecapital International Ltd.	19,220	$12.19M	2.4%	-1.9%	0.018%

Data available starting January 2016

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Today's Range

Now: $599.21

$586.81

$601.28

50 Day Range

MA: $640.41

$546.39

$744.83

52 Week Range

Now: $599.21

$525.99

$1,211.20

Volume

827,813 shs

Average Volume

720,443 shs

Market Capitalization

$65.51 billion

P/E Ratio

15.65

Dividend Yield

0.16%

Beta

0.44

Who are the company insiders with the largest holdings of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top insider investors include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Arthur F Ryan (Director)
Christopher R Fenimore (SVP)
Christopher R Fenimore (CFO)
Joseph L Goldstein (Director)
Jason Pitofsky (VP)
Christine A Poon (Director)
Bonnie L Bassler (Director)
Michael S Brown (Director)
Huda Y Zoghbi (Director)
Learn More about top insider investors at Regeneron Pharmaceuticals.
Who are the major institutional investors of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top institutional investors include:
GAMMA Investing LLC — 0.75%
Assenagon Asset Management S.A. — 0.44%
Chevy Chase Trust Holdings LLC — 0.20%
Rhumbline Advisers — 0.16%
Retirement Systems of Alabama — 0.12%
Robeco Institutional Asset Management B.V. — 0.10%
Learn More about top institutional investors of Regeneron Pharmaceuticals stock.
Which institutional investors are selling Regeneron Pharmaceuticals stock?: In the previous quarter, REGN stock was sold by these institutional investors:
Robeco Institutional Asset Management B.V.
QRG Capital Management Inc.
Wealth Enhancement Advisory Services LLC
Chevy Chase Trust Holdings LLC
Summit Global Investments
Warther Private Wealth LLC
Bessemer Group Inc.
SG Americas Securities LLC
During the previous year, company insiders that have sold Regeneron Pharmaceuticals company stock include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Learn More investors selling Regeneron Pharmaceuticals stock.
Which institutional investors are buying Regeneron Pharmaceuticals stock?: During the last quarter, REGN stock was purchased by institutional investors including:
GAMMA Investing LLC
Assenagon Asset Management S.A.
Retirement Systems of Alabama
Centre Asset Management LLC
Lmcg Investments LLC
GuoLine Advisory Pte Ltd
Greenwood Capital Associates LLC
Factory Mutual Insurance Co.